Bacterial cyanogenesis occurs in the cystic fibrosis lung

European Respiratory Journal

Volumn 32, Issue 2, 2008, Pages 329-333

  Sanderson, K ^a   Wescombe, L ^a   Kirov, S M ^a   Champion, A ^a   Reid, D W ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cyanide; Microaerobic; Pseudomonas aeruginosa; Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; CYANIDE; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOGENESIS; CYSTIC FIBROSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPUTUM ANALYSIS; ADOLESCENT; CASE CONTROL STUDY; GRAM NEGATIVE INFECTION; LUNG; METABOLISM; MICROBIOLOGY; MIDDLE AGED; SPUTUM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CYANIDES; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; VIRULENCE FACTORS;

EID: 56149116399     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00152407     Document Type: Article

References (24)

1. Høiby N. Cystic fibrosis: infection. Schweiz Med Wochenschr 1991; 121: 105-109.
2. Venaille TJ, Ryan G, Robinson BW. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respir Med 1998; 92: 233-240.
3. Yoon SS, Hennigan RF, Hilliard GM, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 2002; 3: 593-603.
4. Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002; 109: 317-325.
5. Carterson AJ, Morici LA, Jackson DW, et al. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol 2004; 186: 6837-6844.
6. Gallagher LA, Manoil C. Pseudomonas aeruginosa PAO1 kills Caenorhabditis elegans by cyanide poisoning. J Bacteriol 2001; 183: 6207-6214.
7. Maresso AW, Deng Q, Pereckas MS, Wakim BT, Barbieri JT. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. Cell Microbiol 2007; 9: 97-105.
8. Blumer C, Haas D. Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis. Arch Microbiol 2000; 173: 170-177.
9. Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 2002; 121: 48-54.
10. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
11. Goldfarb WB, Margraf H. Cyanide production by Pseudomonas aeruginosa. Ann Surg 1967; 165: 104-110.
12. Goldfarb WB, Margraf H. Cyanide production by Pseudomonas aeruginosa. Surg Forum 1964; 15: 467-469.
13. Contreras AA, Evans BW, Moncrief JA, Lindberg RB, Villarreal Y, Mason AD Jr. Some aspects of cyanide-producing capabilities of Pseudomonas aeruginosa strains isolated from burned patient infections. J Trauma 1963; 109: 527-533.
14. Musshoff F, Schmidt P, Daldrup T, Madea B. Cyanide fatalities: case studies of four suicides and one homicide. Am J Forensic Med Pathol 2002; 23: 315-320.
15. Brockbank S, Downey D, Elborn JS, Ennis M. Effect of cystic fibrosis exacerbations on neutrophil function. Int Immunopharmacol 2005; 5: 601-608.
16. Church DA, Kanga JF, Kuhn RJ, et al. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. Pediatr Infect Dis J 1997; 16: 97-105.
17. Hampton MB, Zhivotovsky B, Slater AF, Burgess DH, Orrenius S. Importance of the redox state of cytochrome c during caspase activation in cytosolic extracts. Biochem J 1998; 329: 95-99.
18. Fossati G, Moulding DA, Spiller DG, Moots RJ, White MR, Edwards SW. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 2003; 170: 1964-1972.
19. Stelmaszynska T. Formation of HCN by human phagocytosing neutrophils-1. Chlorination of Staphylococcus epidermidis as a source of HCN. Int J Biochem 1985; 17: 373-379.
20. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997; 24: 137-142.
21. Armstrong DS, Grimwood K, Carlin JB, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 1197-1204.
22. Lewis DA, Jones A, Parkhill J, et al. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol 2005; 33: 56-64.
23. Doring G, Høiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004; 3: 67-91.
24. Doring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16: 749-767.